查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
转甲状腺蛋白类淀粉沉积症治疗的全球市场-占有率，规模，趋势，产业分析:各类型(ATTR-PN，ATTR-CM)，各治疗法，各疾病类型，各流通管道，各地区;各市场区隔预测(2022年～2030年)
市场调查报告书
商品编码
1175546

转甲状腺蛋白类淀粉沉积症治疗的全球市场-占有率，规模，趋势，产业分析:各类型(ATTR-PN，ATTR-CM)，各治疗法，各疾病类型，各流通管道，各地区;各市场区隔预测(2022年～2030年)

Transthyretin Amyloidosis Treatment Market Share, Size, Trends, Industry Analysis Report, By Type (ATTR-PN, ATTR-CM); By Therapy; By Disease Type; By Region; By Distribution Channel; Segment Forecast, 2022 - 2030
出版日期: | 出版商: Polaris Market Research | 英文 117 Pages | 商品交期: 最快1-2个工作天内

价格

全球转甲状腺蛋白类淀粉沉积症治疗的市场规模在2030年前预计达到88亿1,000万美元。

本报告提供全球转甲状腺蛋白类淀粉沉积症治疗市场的相关调查，提供市场洞察，市场分析，竞争情形，企业简介等全面性资讯。

目录

第1章 简介

  • 报告的说明
    • 调查的目的
    • 市场范围
    • 假设
  • 利害关係者

第2章 摘要整理

  • 市场概况

第3章 调查手法

  • 概要
    • 资料探勘
  • 资料来源
    • 一次资讯
    • 二次资讯

第4章 全球转甲状腺蛋白类淀粉沉积症治疗市场洞察

  • 转甲状腺蛋白类淀粉沉积症治疗-产业的概述
  • 转甲状腺蛋白类淀粉沉积症治疗市场动态
    • 促进因素和机会
    • 阻碍因素与课题
  • 波特的五力分析
    • 供给企业谈判力(偏中)
    • 新加入厂商者的威胁(低)
    • 买方议价能力(偏中)
    • 替代品的威胁(偏中)
    • 现有企业间的竞争力(高)
  • 大环境分析
  • 转甲状腺蛋白类淀粉沉积症治疗产业趋势
  • 价值链分析
  • COVID-19影响分析

第5章 全球转甲状腺蛋白类淀粉沉积症治疗市场:不同治疗

  • 主要调查结果
  • 简介
    • 全球转甲状腺蛋白类淀粉沉积症治疗市场(10亿美元)(2018年～2030年):不同治疗
  • 标靶治疗
    • 全球转甲状腺蛋白类淀粉沉积症治疗市场(10亿美元)(2018年～2030年):标靶治疗:各地区
  • 支持疗法
    • 全球转甲状腺蛋白类淀粉沉积症治疗市场(10亿美元)(2018年～2030年):支持疗法:各地区
  • 开发平台(管线)疗法
    • 全球转甲状腺蛋白类淀粉沉积症治疗市场(10亿美元)(2018年～2030年):开发平台(管线)疗法:各地区

第6章 全球转甲状腺蛋白类淀粉沉积症治疗市场:各疾病类型

  • 主要调查结果
  • 简介
    • 全球转甲状腺蛋白类淀粉沉积症治疗市场(10亿美元)(2018年～2030年):各疾病类型
  • 遗传性转甲状腺蛋白类淀粉沉积症
    • 全球转甲状腺蛋白类淀粉沉积症治疗市场(10亿美元)(2018年～2030年):遗传性转甲状腺蛋白类淀粉沉积症:各地区
  • 野生型转甲状腺蛋白类淀粉沉积症
    • 全球转甲状腺蛋白类淀粉沉积症治疗市场(10亿美元)(2018年～2030年):野生型转甲状腺蛋白类淀粉沉积症:各地区

第7章 全球转甲状腺蛋白类淀粉沉积症治疗市场:各类型

  • 主要调查结果
  • 简介
    • 全球转甲状腺蛋白类淀粉沉积症治疗市场(10亿美元)(2018年～2030年):各类型
  • ATTR-CM
    • 全球转甲状腺蛋白类淀粉沉积症治疗市场(10亿美元)(2018年～2030年):ATTR-CM:各地区
  • ATTR-PN
    • 全球转甲状腺蛋白类淀粉沉积症治疗市场(10亿美元)(2018年～2030年):ATTR-PN:各地区

第8章 全球转甲状腺蛋白类淀粉沉积症治疗市场:各流通管道

  • 主要调查结果
  • 简介
    • 全球转甲状腺蛋白类淀粉沉积症治疗市场(10亿美元)(2018年～2030年):各流通管道
  • 医院药局
    • 全球转甲状腺蛋白类淀粉沉积症治疗市场(10亿美元)(2018年～2030年):医院药局:各地区
  • 线上药局
    • 全球转甲状腺蛋白类淀粉沉积症治疗市场(10亿美元)(2018年～2030年):线上药局:各地区

第9章 全球转甲状腺蛋白类淀粉沉积症治疗市场:各地区

  • 主要调查结果
  • 简介
    • 转甲状腺蛋白类淀粉沉积症治疗市场评估(10亿美元)(2018年～2030年):各地区
  • 转甲状腺蛋白类淀粉沉积症治疗市场-北美
  • 转甲状腺蛋白类淀粉沉积症治疗市场-欧洲
  • 转甲状腺蛋白类淀粉沉积症治疗市场-亚太地区
  • 转甲状腺蛋白类淀粉沉积症治疗市场-中东及非洲
  • 转甲状腺蛋白类淀粉沉积症治疗市场-南美

第10章 竞争情形

  • 扩大和收购的分析
    • 扩大
    • 收购
  • 伙伴关係/合作/协定/展示会

第11章 企业简介

  • Pfizer
  • Johnson & Johnson Services
  • Ionis Pharmaceuticals
  • Alnylam Pharmaceuticals
  • BridgeBio Pharma
  • Bristol-Myers
  • Acrotech Biopharma
  • AstraZeneca
  • Astellas Pharma
  • Gala Coral Group
  • Prothena
  • SOM Biotech
Product Code: PM2778

The transthyretin amyloidosis treatment market size is expected to reach USD 8.81 billion by 2030, according to a new study by Polaris Market Research. The report "Transthyretin Amyloidosis Treatment Market Share, Size, Trends, Industry Analysis Report, By Type (ATTR-PN, ATTR-CM); By Therapy; By Disease Type; By Distribution Channel; By Region; Segment Forecast, 2022 - 2030" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The rising number of geriatrics in the patient population and an increasing number of geriatrics developing chronic disorders are anticipated to drive the growth of transthyretin amyloidosis treatment. Since transthyretin amyloidosis treatment is expensive, adopting this therapy is higher in high-income regions in developing economies.

Moreover, the market is estimated to increase the influx of pipeline drugs in lieu of active investments by leading players in developing these drugs, thereby augmenting the growth of its treatment market. The increasing awareness of treating this disease by physicians and key market players, along with support provided by government aids to improve the adoption of these novel therapies, is expected to drive the growth of the market.

Transthyretin amyloid cardiomyopathy (ATTR-CM) is an under-diagnosed condition causing heart failure in older adults. It is a type of systemic amyloidoses disorder caused by an accumulation of a protein that forms amyloid fibrils in several tissues. The condition is a silent cause of deteriorating organ health and may prove fatal if undiagnosed. Some factors causing this condition are co-relation with its hereditary nature, unhealthy food habits and a sedentary lifestyle. This coupled with the rising prevalence of the disease, is anticipated to drive the growth of this segment owing to the increasing patient population diagnosed with this disease.

Transthyretin amyloidal polyneuropathy (ATTR-PN), however, is a separate condition originating from a similar pathophysiology that affects the nervous system and results in multiple organ failures as the disease progresses due to nerve damage. Major market players developing key drugs to manage and treat this condition, along with regulatory approvals granted by government regulatory bodies to improve product reach across high-income countries owing to higher healthcare expenditure, are anticipated to drive the growth of this segment. The market growth is also driven owing to consistent clinical trials conducted by various academic and research institutes developing pipeline drugs with promising results.

Transthyretin Amyloidosis Treatment Market Report Highlights

ATTR-CM segment is anticipated to grow at a high CAGR over the forecast period owing to the rising incidence of the condition among patients suffering from cardiomyopathy along with better availability of treatment options for the segment.

Targeted therapy accounted major revenue share, which is accelerated by the increasing applications alongside a large number of trials and studies proving its effective treatment owing to the complex nature of transthyretin amyloidosis as a disease.

Hereditary transthyretin amyloidosis is expected to hold a significant market share over the forecast period due to the increasing patient pool suffering from the condition, along with awareness campaigns conducted by key government organizations.

North America is expected to grow dominantly over the projected period because of the strategic presence of key companies and research institutions expediting the availability of treatment in the region.

The global players include Pfizer, Johnson & Johnson Services, Ionis Pharmaceuticals, Alnylam Pharmaceuticals, BridgeBio Pharma.

Polaris Market Research has segmented the Transthyretin Amyloidosis Treatment market report based on type, therapy, disease type, distribution channel and region:

Transthyretin Amyloidosis Treatment, Type Outlook (Revenue - USD Billion, 2018 - 2030)

ATTR-CM

ATTR-PN

Transthyretin Amyloidosis Treatment, Therapy Outlook (Revenue - USD Billion, 2018 - 2030)

Targeted Therapy

Supportive Therapy

Pipeline Therapy

Transthyretin Amyloidosis Treatment, By Disease Outlook (Revenue - USD Billion, 2018 - 2030)

Hereditary transthyretin amyloidosis

Wild type transthyretin amyloidosis

Transthyretin Amyloidosis Treatment, By Distribution Channel Outlook (Revenue - USD Billion, 2018 - 2030)

Hospital Pharmacy

Online Pharmacy

Transthyretin Amyloidosis Treatment, Regional Outlook (Revenue - USD Billion, 2018 - 2030)

North America

U.S

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Latin America

Argentina

Brazil

Mexico

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Transthyretin Amyloidosis Treatment Market Insights

  • 4.1. Transthyretin Amyloidosis Treatment - Industry Snapshot
  • 4.2. Transthyretin Amyloidosis Treatment Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing incidences of diseases
      • 4.2.1.2. Rising awareness about diseases
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High cost of treatment
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Transthyretin Amyloidosis Treatment Industry Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Transthyretin Amyloidosis Treatment Market, by Therapy

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Transthyretin Amyloidosis Treatment Market, by Therapy, 2018 - 2030 (USD Billion)
  • 5.3. Targeted Therapy
    • 5.3.1. Global Transthyretin Amyloidosis Treatment Market, by Targeted Therapy, by Region, 2018 - 2030 (USD Billion)
  • 5.4. Supportive Therapy
    • 5.4.1. Global Transthyretin Amyloidosis Treatment Market, by Supportive Therapy, by Region, 2018 - 2030 (USD Billion)
  • 5.5. Pipeline Therapy
    • 5.5.1. Global Transthyretin Amyloidosis Treatment Market, by Pipeline Therapy, by Region, 2018 - 2030 (USD Billion)

6. Global Transthyretin Amyloidosis Treatment Market, by Disease Type

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Transthyretin Amyloidosis Treatment Market, by Disease Type, 2018 - 2030 (USD Billion)
  • 6.3. Hereditary transthyretin amyloidosis
    • 6.3.1. Global Transthyretin Amyloidosis Treatment Market, by Hereditary transthyretin amyloidosis, by Region, 2018 - 2030 (USD Billion)
  • 6.4. Wild-type transthyretin amyloidosis
    • 6.4.1. Global Transthyretin Amyloidosis Treatment Market, by Wild-type transthyretin amyloidosis, by Region, 2018 - 2030 (USD Billion)

7. Global Transthyretin Amyloidosis Treatment Market, by Type

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Transthyretin Amyloidosis Treatment Market, by Type, 2018 - 2030 (USD Billion)
  • 7.3. ATTR-CM
    • 7.3.1. Global Transthyretin Amyloidosis Treatment Market, by ATTR-CM, by Region, 2018 - 2030 (USD Billion)
  • 7.4. ATTR-PN
    • 7.4.1. Global Transthyretin Amyloidosis Treatment Market, by ATTR-PN, by Region, 2018 - 2030 (USD Billion)

8. Global Transthyretin Amyloidosis Treatment Market, by Distribution Channel

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Transthyretin Amyloidosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • 8.3. Hospital Pharmacy
    • 8.3.1. Global Transthyretin Amyloidosis Treatment Market, by Hospital Pharmacy, by Region, 2018 - 2030 (USD Billion)
  • 8.4. Online Pharmacy
    • 8.4.1. Global Transthyretin Amyloidosis Treatment Market, by Online Pharmacy, by Region, 2018 - 2030 (USD Billion)

9. Global Transthyretin Amyloidosis Treatment Market, by Geography

  • 9.1. Key findings
  • 9.2. Introduction
    • 9.2.1. Transthyretin Amyloidosis Treatment Market Assessment, By Geography, 2018 - 2030 (USD Billion)
  • 9.3. Transthyretin Amyloidosis Treatment Market - North America
    • 9.3.1. North America: Transthyretin Amyloidosis Treatment Market, by Therapy, 2018 - 2030 (USD Billion)
    • 9.3.2. North America: Transthyretin Amyloidosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Billion)
    • 9.3.3. North America: Transthyretin Amyloidosis Treatment Market, by Disease Type, 2018 - 2030 (USD Billion)
    • 9.3.4. North America: Transthyretin Amyloidosis Treatment Market, by Type, 2018 - 2030 (USD Billion)
    • 9.3.5. Transthyretin Amyloidosis Treatment Market - U.S.
      • 9.3.5.1. U.S.: Transthyretin Amyloidosis Treatment Market, by Therapy, 2018 - 2030 (USD Billion)
      • 9.3.5.2. U.S.: Transthyretin Amyloidosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Billion)
      • 9.3.5.3. U.S.: Transthyretin Amyloidosis Treatment Market, by Disease Type, 2018 - 2030 (USD Billion)
      • 9.3.5.4. U.S.: Transthyretin Amyloidosis Treatment Market, by Type, 2018 - 2030 (USD Billion)
    • 9.3.6. Transthyretin Amyloidosis Treatment Market - Canada
      • 9.3.6.1. Canada: Transthyretin Amyloidosis Treatment Market, by Therapy, 2018 - 2030 (USD Billion)
      • 9.3.6.2. Canada: Transthyretin Amyloidosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Billion)
      • 9.3.6.3. Canada: Transthyretin Amyloidosis Treatment Market, by Disease Type, 2018 - 2030 (USD Billion)
      • 9.3.6.4. Canada: Transthyretin Amyloidosis Treatment Market, by Type, 2018 - 2030 (USD Billion)
  • 9.4. Transthyretin Amyloidosis Treatment Market - Europe
    • 9.4.1. Europe: Transthyretin Amyloidosis Treatment Market, by Therapy, 2018 - 2030 (USD Billion)
    • 9.4.2. Europe: Transthyretin Amyloidosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Billion)
    • 9.4.3. Europe: Transthyretin Amyloidosis Treatment Market, by Disease Type, 2018 - 2030 (USD Billion)
    • 9.4.4. Europe: Transthyretin Amyloidosis Treatment Market, by Type, 2018 - 2030 (USD Billion)
    • 9.4.5. Transthyretin Amyloidosis Treatment Market - UK
      • 9.4.5.1. UK: Transthyretin Amyloidosis Treatment Market, by Therapy, 2018 - 2030 (USD Billion)
      • 9.4.5.2. UK: Transthyretin Amyloidosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Billion)
      • 9.4.5.3. UK: Transthyretin Amyloidosis Treatment Market, by Disease Type, 2018 - 2030 (USD Billion)
      • 9.4.5.4. UK: Transthyretin Amyloidosis Treatment Market, by Type, 2018 - 2030 (USD Billion)
    • 9.4.6. Transthyretin Amyloidosis Treatment Market - France
      • 9.4.6.1. France: Transthyretin Amyloidosis Treatment Market, by Therapy, 2018 - 2030 (USD Billion)
      • 9.4.6.2. France: Transthyretin Amyloidosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Billion)
      • 9.4.6.3. France: Transthyretin Amyloidosis Treatment Market, by Disease Type, 2018 - 2030 (USD Billion)
      • 9.4.6.4. France: Transthyretin Amyloidosis Treatment Market, by Type, 2018 - 2030 (USD Billion)
    • 9.4.7. Transthyretin Amyloidosis Treatment Market - Germany
      • 9.4.7.1. Germany: Transthyretin Amyloidosis Treatment Market, by Therapy, 2018 - 2030 (USD Billion)
      • 9.4.7.2. Germany: Transthyretin Amyloidosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Billion)
      • 9.4.7.3. Germany: Transthyretin Amyloidosis Treatment Market, by Disease Type, 2018 - 2030 (USD Billion)
      • 9.4.7.4. Germany: Transthyretin Amyloidosis Treatment Market, by Type, 2018 - 2030 (USD Billion)
    • 9.4.8. Transthyretin Amyloidosis Treatment Market - Italy
      • 9.4.8.1. Italy: Transthyretin Amyloidosis Treatment Market, by Therapy, 2018 - 2030 (USD Billion)
      • 9.4.8.2. Italy: Transthyretin Amyloidosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Billion)
      • 9.4.8.3. Italy: Transthyretin Amyloidosis Treatment Market, by Disease Type, 2018 - 2030 (USD Billion)
      • 9.4.8.4. Italy: Transthyretin Amyloidosis Treatment Market, by Type, 2018 - 2030 (USD Billion)
    • 9.4.9. Transthyretin Amyloidosis Treatment Market - Spain
      • 9.4.9.1. Spain: Transthyretin Amyloidosis Treatment Market, by Therapy, 2018 - 2030 (USD Billion)
      • 9.4.9.2. Spain: Transthyretin Amyloidosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Billion)
      • 9.4.9.3. Spain: Transthyretin Amyloidosis Treatment Market, by Disease Type, 2018 - 2030 (USD Billion)
      • 9.4.9.4. Spain: Transthyretin Amyloidosis Treatment Market, by Type, 2018 - 2030 (USD Billion)
    • 9.4.10. Transthyretin Amyloidosis Treatment Market - Netherlands
      • 9.4.10.1. Netherlands: Transthyretin Amyloidosis Treatment Market, by Therapy, 2018 - 2030 (USD Billion)
      • 9.4.10.2. Netherlands: Transthyretin Amyloidosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Billion)
      • 9.4.10.3. Netherlands: Transthyretin Amyloidosis Treatment Market, by Disease Type, 2018 - 2030 (USD Billion)
      • 9.4.10.4. Netherlands: Transthyretin Amyloidosis Treatment Market, by Type, 2018 - 2030 (USD Billion)
    • 9.4.11. Transthyretin Amyloidosis Treatment Market - Russia
      • 9.4.11.1. Russia: Transthyretin Amyloidosis Treatment Market, by Therapy, 2018 - 2030 (USD Billion)
      • 9.4.11.2. Russia.: Transthyretin Amyloidosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Billion)
      • 9.4.11.3. Russia: Transthyretin Amyloidosis Treatment Market, by Disease Type, 2018 - 2030 (USD Billion)
      • 9.4.11.4. Russia: Transthyretin Amyloidosis Treatment Market, by Type, 2018 - 2030 (USD Billion)
  • 9.5. Transthyretin Amyloidosis Treatment Market - Asia Pacific
    • 9.5.1. Asia Pacific: Transthyretin Amyloidosis Treatment Market, by Therapy, 2018 - 2030 (USD Billion)
    • 9.5.2. Asia Pacific: Transthyretin Amyloidosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Billion)
    • 9.5.3. Asia Pacific: Transthyretin Amyloidosis Treatment Market, by Disease Type, 2018 - 2030 (USD Billion)
    • 9.5.4. Asia Pacific: Transthyretin Amyloidosis Treatment Market, by Type, 2018 - 2030 (USD Billion)
    • 9.5.5. Transthyretin Amyloidosis Treatment Market - China
      • 9.5.5.1. China: Transthyretin Amyloidosis Treatment Market, by Therapy, 2018 - 2030 (USD Billion)
      • 9.5.5.2. China.: Transthyretin Amyloidosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Billion)
      • 9.5.5.3. China: Transthyretin Amyloidosis Treatment Market, by Disease Type, 2018 - 2030 (USD Billion)
      • 9.5.5.4. China: Transthyretin Amyloidosis Treatment Market, by Type, 2018 - 2030 (USD Billion)
    • 9.5.6. Transthyretin Amyloidosis Treatment Market - India
      • 9.5.6.1. India: Transthyretin Amyloidosis Treatment Market, by Therapy, 2018 - 2030 (USD Billion)
      • 9.5.6.2. India.: Transthyretin Amyloidosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Billion)
      • 9.5.6.3. India: Transthyretin Amyloidosis Treatment Market, by Disease Type, 2018 - 2030 (USD Billion)
      • 9.5.6.4. India: Transthyretin Amyloidosis Treatment Market, by Type, 2018 - 2030 (USD Billion)
    • 9.5.7. Transthyretin Amyloidosis Treatment Market - Japan
      • 9.5.7.1. Japan: Transthyretin Amyloidosis Treatment Market, by Therapy, 2018 - 2030 (USD Billion)
      • 9.5.7.2. Japan.: Transthyretin Amyloidosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Billion)
      • 9.5.7.3. Japan: Transthyretin Amyloidosis Treatment Market, by Disease Type, 2018 - 2030 (USD Billion)
      • 9.5.7.4. Japan: Transthyretin Amyloidosis Treatment Market, by Type, 2018 - 2030 (USD Billion)
    • 9.5.8. Transthyretin Amyloidosis Treatment Market - Malaysia
      • 9.5.8.1. Malaysia: Transthyretin Amyloidosis Treatment Market, by Therapy, 2018 - 2030 (USD Billion)
      • 9.5.8.2. Malaysia.: Transthyretin Amyloidosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Billion)
      • 9.5.8.3. Malaysia: Transthyretin Amyloidosis Treatment Market, by Disease Type, 2018 - 2030 (USD Billion)
      • 9.5.8.4. Malaysia: Transthyretin Amyloidosis Treatment Market, by Type, 2018 - 2030 (USD Billion)
    • 9.5.9. Transthyretin Amyloidosis Treatment Market - Indonesia
      • 9.5.9.1. Indonesia: Transthyretin Amyloidosis Treatment Market, by Therapy, 2018 - 2030 (USD Billion)
      • 9.5.9.2. Indonesia.: Transthyretin Amyloidosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Billion)
      • 9.5.9.3. Indonesia: Transthyretin Amyloidosis Treatment Market, by Disease Type, 2018 - 2030 (USD Billion)
      • 9.5.9.4. Indonesia: Transthyretin Amyloidosis Treatment Market, by Type, 2018 - 2030 (USD Billion)
    • 9.5.10. Transthyretin Amyloidosis Treatment Market - South Korea
      • 9.5.10.1. South Korea: Transthyretin Amyloidosis Treatment Market, by Therapy, 2018 - 2030 (USD Billion)
      • 9.5.10.2. South Korea.: Transthyretin Amyloidosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Billion)
      • 9.5.10.3. South Korea: Transthyretin Amyloidosis Treatment Market, by Disease Type, 2018 - 2030 (USD Billion)
      • 9.5.10.4. South Korea: Transthyretin Amyloidosis Treatment Market, by Type, 2018 - 2030 (USD Billion)
  • 9.6. Transthyretin Amyloidosis Treatment Market - Middle East & Africa
    • 9.6.1. Middle East & Africa: Transthyretin Amyloidosis Treatment Market, by Therapy, 2018 - 2030 (USD Billion)
    • 9.6.2. Middle East & Africa: Transthyretin Amyloidosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Billion)
    • 9.6.3. Middle East & Africa: Transthyretin Amyloidosis Treatment Market, by Disease Type, 2018 - 2030 (USD Billion)
    • 9.6.4. Middle East & Africa: Transthyretin Amyloidosis Treatment Market, by Type, 2018 - 2030 (USD Billion)
    • 9.6.5. Transthyretin Amyloidosis Treatment Market - Saudi Arabia
      • 9.6.5.1. Saudi Arabia: Transthyretin Amyloidosis Treatment Market, by Therapy, 2018 - 2030 (USD Billion)
      • 9.6.5.2. Saudi Arabia: Transthyretin Amyloidosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Billion)
      • 9.6.5.3. Saudi Arabia: Transthyretin Amyloidosis Treatment Market, by Disease Type, 2018 - 2030 (USD Billion)
      • 9.6.5.4. Saudi Arabia: Transthyretin Amyloidosis Treatment Market, by Type, 2018 - 2030 (USD Billion)
    • 9.6.6. Transthyretin Amyloidosis Treatment Market - South Africa
      • 9.6.6.1. South Africa: Transthyretin Amyloidosis Treatment Market, by Therapy, 2018 - 2030 (USD Billion)
      • 9.6.6.2. South Africa: Transthyretin Amyloidosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Billion)
      • 9.6.6.3. South Africa: Transthyretin Amyloidosis Treatment Market, by Disease Type, 2018 - 2030 (USD Billion)
      • 9.6.6.4. South Africa: Transthyretin Amyloidosis Treatment Market, by Type, 2018 - 2030 (USD Billion)
    • 9.6.7. Transthyretin Amyloidosis Treatment Market - Israel
      • 9.6.7.1. Israel: Transthyretin Amyloidosis Treatment Market, by Therapy, 2018 - 2030 (USD Billion)
      • 9.6.7.2. Israel: Transthyretin Amyloidosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Billion)
      • 9.6.7.3. Israel: Transthyretin Amyloidosis Treatment Market, by Disease Type, 2018 - 2030 (USD Billion)
      • 9.6.7.4. Israel: Transthyretin Amyloidosis Treatment Market, by Type, 2018 - 2030 (USD Billion)
    • 9.6.8. Transthyretin Amyloidosis Treatment Market - UAE
      • 9.6.8.1. UAE: Transthyretin Amyloidosis Treatment Market, by Therapy, 2018 - 2030 (USD Billion)
      • 9.6.8.2. UAE: Transthyretin Amyloidosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Billion)
      • 9.6.8.3. UAE: Transthyretin Amyloidosis Treatment Market, by Disease Type, 2018 - 2030 (USD Billion)
      • 9.6.8.4. UAE: Transthyretin Amyloidosis Treatment Market, by Type, 2018 - 2030 (USD Billion)
  • 9.7. Transthyretin Amyloidosis Treatment Market - Latin America
    • 9.7.1. Latin America: Transthyretin Amyloidosis Treatment Market, by Therapy, 2018 - 2030 (USD Billion)
    • 9.7.2. Latin America: Transthyretin Amyloidosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Billion)
    • 9.7.3. Latin America: Transthyretin Amyloidosis Treatment Market, by Disease Type, 2018 - 2030 (USD Billion)
    • 9.7.4. Latin America: Transthyretin Amyloidosis Treatment Market, by Type, 2018 - 2030 (USD Billion)
    • 9.7.5. Transthyretin Amyloidosis Treatment Market - Mexico
      • 9.7.5.1. Mexico: Transthyretin Amyloidosis Treatment Market, by Therapy, 2018 - 2030 (USD Billion)
      • 9.7.5.2. Mexico: Transthyretin Amyloidosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Billion)
      • 9.7.5.3. Mexico: Transthyretin Amyloidosis Treatment Market, by Disease Type, 2018 - 2030 (USD Billion)
      • 9.7.5.4. Mexico: Transthyretin Amyloidosis Treatment Market, by Type, 2018 - 2030 (USD Billion)
    • 9.7.6. Transthyretin Amyloidosis Treatment Market - Brazil
      • 9.7.6.1. Brazil: Transthyretin Amyloidosis Treatment Market, by Therapy, 2018 - 2030 (USD Billion)
      • 9.7.6.2. Brazil: Transthyretin Amyloidosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Billion)
      • 9.7.6.3. Brazil: Transthyretin Amyloidosis Treatment Market, by Disease Type, 2018 - 2030 (USD Billion)
      • 9.7.6.4. Brazil: Transthyretin Amyloidosis Treatment Market, by Type, 2018 - 2030 (USD Billion)
    • 9.7.7. Transthyretin Amyloidosis Treatment Market - Argentina
      • 9.7.7.1. Argentina: Transthyretin Amyloidosis Treatment Market, by Therapy, 2018 - 2030 (USD Billion)
      • 9.7.7.2. Argentina: Transthyretin Amyloidosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Billion)
      • 9.7.7.3. Argentina: Transthyretin Amyloidosis Treatment Market, by Disease Type, 2018 - 2030 (USD Billion)
      • 9.7.7.4. Argentina: Transthyretin Amyloidosis Treatment Market, by Type, 2018 - 2030 (USD Billion)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion
    • 10.1.2. Acquisitions
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

  • 11.1. Pfizer
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Recent Development
  • 11.2. Johnson & Johnson Services
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Benchmarking
    • 11.2.4. Recent Development
  • 11.3. Ionis Pharmaceuticals
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Benchmarking
    • 11.3.4. Recent Development
  • 11.4. Alnylam Pharmaceuticals
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Benchmarking
    • 11.4.4. Recent Development
  • 11.5. BridgeBio Pharma
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Benchmarking
    • 11.5.4. Recent Development
  • 11.6. Bristol-Myers
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Benchmarking
    • 11.6.4. Recent Development
  • 11.7. Acrotech Biopharma
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Benchmarking
    • 11.7.4. Recent Development
  • 11.8. AstraZeneca
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Benchmarking
    • 11.8.4. Recent Development
  • 11.9. Astellas Pharma
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Benchmarking
    • 11.9.4. Recent Development
  • 11.10. Gala Coral Group
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Benchmarking
    • 11.10.4. Recent Development
  • 11.11. Prothena
    • 11.11.1. Company Overview
    • 11.11.2. Financial Performance
    • 11.11.3. Product Benchmarking
    • 11.11.4. Recent Development
  • 11.12. SOM Biotech
    • 11.12.1. Company Overview
    • 11.12.2. Financial Performance
    • 11.12.3. Product Benchmarking
    • 11.12.4. Recent Development

List of Tables

  • Table 1 Global Transthyretin Amyloidosis Treatment Market, by Therapy, by Region, 2018 - 2030 (USD Billion)
  • Table 2 Global Transthyretin Amyloidosis Treatment Market, by Disease Type, by Region, 2018 - 2030 (USD Billion)
  • Table 3 Global Transthyretin Amyloidosis Treatment Market, by Type, by Region, 2018 - 2030 (USD Billion)
  • Table 4 Global Transthyretin Amyloidosis Treatment Market, by Distribution Channel, by Region, 2018 - 2030 (USD Billion)
  • Table 5 Transthyretin Amyloidosis Treatment Market Assessment, By Geography, 2018 - 2030 (USD Billion)
  • Table 6 North America: Transthyretin Amyloidosis Treatment Market, by Therapy, 2018 - 2030 (USD Billion)
  • Table 7 North America: Transthyretin Amyloidosis Treatment Market, by Disease Type, 2018 - 2030 (USD Billion)
  • Table 8 North America: Transthyretin Amyloidosis Treatment Market, by Type, 2018 - 2030 (USD Billion)
  • Table 9 North America: Transthyretin Amyloidosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 10 U.S.: Transthyretin Amyloidosis Treatment Market, by Therapy, 2018 - 2030 (USD Billion)
  • Table 11 U.S.: Transthyretin Amyloidosis Treatment Market, by Disease Type, 2018 - 2030 (USD Billion)
  • Table 12 U.S.: Transthyretin Amyloidosis Treatment Market, by Type, 2018 - 2030 (USD Billion)
  • Table 13 U.S.: Transthyretin Amyloidosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 14 Canada: Transthyretin Amyloidosis Treatment Market, by Therapy, 2018 - 2030 (USD Billion)
  • Table 15 Canada: Transthyretin Amyloidosis Treatment Market, by Disease Type, 2018 - 2030 (USD Billion)
  • Table 16 Canada: Transthyretin Amyloidosis Treatment Market, by Type, 2018 - 2030 (USD Billion)
  • Table 17 Canada: Transthyretin Amyloidosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 18 Europe: Transthyretin Amyloidosis Treatment Market, by Therapy, 2018 - 2030 (USD Billion)
  • Table 19 Europe: Transthyretin Amyloidosis Treatment Market, by Disease Type, 2018 - 2030 (USD Billion)
  • Table 20 Europe: Transthyretin Amyloidosis Treatment Market, by Type, 2018 - 2030 (USD Billion)
  • Table 21 Europe: Transthyretin Amyloidosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 22 Germany: Transthyretin Amyloidosis Treatment Market, by Therapy, 2018 - 2030 (USD Billion)
  • Table 23 Germany: Transthyretin Amyloidosis Treatment Market, by Disease Type, 2018 - 2030 (USD Billion)
  • Table 24 Germany: Transthyretin Amyloidosis Treatment Market, by Type, 2018 - 2030 (USD Billion)
  • Table 25 Germany: Transthyretin Amyloidosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 26 France: Transthyretin Amyloidosis Treatment Market, by Therapy, 2018 - 2030 (USD Billion)
  • Table 27 France: Transthyretin Amyloidosis Treatment Market, by Disease Type, 2018 - 2030 (USD Billion)
  • Table 28 France: Transthyretin Amyloidosis Treatment Market, by Type, 2018 - 2030 (USD Billion)
  • Table 29 France: Transthyretin Amyloidosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 30 UK: Transthyretin Amyloidosis Treatment Market, by Therapy, 2018 - 2030 (USD Billion)
  • Table 31 UK: Transthyretin Amyloidosis Treatment Market, by Disease Type, 2018 - 2030 (USD Billion)
  • Table 32 UK: Transthyretin Amyloidosis Treatment Market, by Type, 2018 - 2030 (USD Billion)
  • Table 33 UK: Transthyretin Amyloidosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 34 Italy: Transthyretin Amyloidosis Treatment Market, by Therapy, 2018 - 2030 (USD Billion)
  • Table 35 Italy: Transthyretin Amyloidosis Treatment Market, by Disease Type, 2018 - 2030 (USD Billion)
  • Table 36 Italy: Transthyretin Amyloidosis Treatment Market, by Type, 2018 - 2030 (USD Billion)
  • Table 37 Italy: Transthyretin Amyloidosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 38 Netherlands: Transthyretin Amyloidosis Treatment Market, by Therapy, 2018 - 2030 (USD Billion)
  • Table 39 Netherlands: Transthyretin Amyloidosis Treatment Market, by Disease Type, 2018 - 2030 (USD Billion)
  • Table 40 Netherlands: Transthyretin Amyloidosis Treatment Market, by Type, 2018 - 2030 (USD Billion)
  • Table 41 Netherlands: Transthyretin Amyloidosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 42 Spain: Transthyretin Amyloidosis Treatment Market, by Therapy, 2018 - 2030 (USD Billion)
  • Table 43 Spain: Transthyretin Amyloidosis Treatment Market, by Disease Type, 2018 - 2030 (USD Billion)
  • Table 44 Spain: Transthyretin Amyloidosis Treatment Market, by Type, 2018 - 2030 (USD Billion)
  • Table 45 Spain: Transthyretin Amyloidosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 46 Russia: Transthyretin Amyloidosis Treatment Market, by Therapy, 2018 - 2030 (USD Billion)
  • Table 47 Russia: Transthyretin Amyloidosis Treatment Market, by Disease Type, 2018 - 2030 (USD Billion)
  • Table 48 Russia: Transthyretin Amyloidosis Treatment Market, by Type, 2018 - 2030 (USD Billion)
  • Table 49 Russia: Transthyretin Amyloidosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 50 Asia Pacific: Transthyretin Amyloidosis Treatment Market, by Therapy, 2018 - 2030 (USD Billion)
  • Table 51 Asia Pacific: Transthyretin Amyloidosis Treatment Market, by Disease Type, 2018 - 2030 (USD Billion)
  • Table 52 Asia Pacific: Transthyretin Amyloidosis Treatment Market, by Type, 2018 - 2030 (USD Billion)
  • Table 53 Asia Pacific: Transthyretin Amyloidosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 54 China: Transthyretin Amyloidosis Treatment Market, by Therapy, 2018 - 2030 (USD Billion)
  • Table 55 China: Transthyretin Amyloidosis Treatment Market, by Disease Type, 2018 - 2030 (USD Billion)
  • Table 56 China: Transthyretin Amyloidosis Treatment Market, by Type, 2018 - 2030 (USD Billion)
  • Table 57 China: Transthyretin Amyloidosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 58 Japan: Transthyretin Amyloidosis Treatment Market, by Therapy, 2018 - 2030 (USD Billion)
  • Table 59 Japan: Transthyretin Amyloidosis Treatment Market, by Disease Type, 2018 - 2030 (USD Billion)
  • Table 60 Japan: Transthyretin Amyloidosis Treatment Market, by Type, 2018 - 2030 (USD Billion)
  • Table 61 Japan: Transthyretin Amyloidosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 62 India: Transthyretin Amyloidosis Treatment Market, by Therapy, 2018 - 2030 (USD Billion)
  • Table 63 India: Transthyretin Amyloidosis Treatment Market, by Disease Type, 2018 - 2030 (USD Billion)
  • Table 64 India: Transthyretin Amyloidosis Treatment Market, by Type, 2018 - 2030 (USD Billion)
  • Table 65 India: Transthyretin Amyloidosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 66 Indonesia: Transthyretin Amyloidosis Treatment Market, by Therapy, 2018 - 2030 (USD Billion)
  • Table 67 Indonesia: Transthyretin Amyloidosis Treatment Market, by Disease Type, 2018 - 2030 (USD Billion)
  • Table 68 Indonesia: Transthyretin Amyloidosis Treatment Market, by Type, 2018 - 2030 (USD Billion)
  • Table 69 Indonesia: Transthyretin Amyloidosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 70 Malaysia: Transthyretin Amyloidosis Treatment Market, by Therapy, 2018 - 2030 (USD Billion)
  • Table 71 Malaysia: Transthyretin Amyloidosis Treatment Market, by Disease Type, 2018 - 2030 (USD Billion)
  • Table 72 Malaysia: Transthyretin Amyloidosis Treatment Market, by Type, 2018 - 2030 (USD Billion)
  • Table 73 Malaysia: Transthyretin Amyloidosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 74 South Korea: Transthyretin Amyloidosis Treatment Market, by Therapy, 2018 - 2030 (USD Billion)
  • Table 75 South Korea: Transthyretin Amyloidosis Treatment Market, by Disease Type, 2018 - 2030 (USD Billion)
  • Table 76 South Korea: Transthyretin Amyloidosis Treatment Market, by Type, 2018 - 2030 (USD Billion)
  • Table 77 South Korea: Transthyretin Amyloidosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 78 Latin America: Transthyretin Amyloidosis Treatment Market, by Therapy, 2018 - 2030 (USD Billion)
  • Table 79 Latin America: Transthyretin Amyloidosis Treatment Market, by Disease Type, 2018 - 2030 (USD Billion)
  • Table 80 Latin America: Transthyretin Amyloidosis Treatment Market, by Type, 2018 - 2030 (USD Billion)
  • Table 81 Latin America: Transthyretin Amyloidosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 82 Brazil: Transthyretin Amyloidosis Treatment Market, by Therapy, 2018 - 2030 (USD Billion)
  • Table 83 Brazil: Transthyretin Amyloidosis Treatment Market, by Disease Type, 2018 - 2030 (USD Billion)
  • Table 84 Brazil: Transthyretin Amyloidosis Treatment Market, by Type, 2018 - 2030 (USD Billion)
  • Table 85 Brazil: Transthyretin Amyloidosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 86 Mexico: Transthyretin Amyloidosis Treatment Market, by Therapy, 2018 - 2030 (USD Billion)
  • Table 87 Mexico: Transthyretin Amyloidosis Treatment Market, by Disease Type, 2018 - 2030 (USD Billion)
  • Table 88 Mexico: Transthyretin Amyloidosis Treatment Market, by Type, 2018 - 2030 (USD Billion)
  • Table 89 Mexico: Transthyretin Amyloidosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 90 Argentina: Transthyretin Amyloidosis Treatment Market, by Therapy, 2018 - 2030 (USD Billion)
  • Table 91 Argentina: Transthyretin Amyloidosis Treatment Market, by Disease Type, 2018 - 2030 (USD Billion)
  • Table 92 Argentina: Transthyretin Amyloidosis Treatment Market, by Type, 2018 - 2030 (USD Billion)
  • Table 93 Argentina: Transthyretin Amyloidosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 94 Middle East & Africa: Transthyretin Amyloidosis Treatment Market, by Therapy, 2018 - 2030 (USD Billion)
  • Table 95 Middle East & Africa: Transthyretin Amyloidosis Treatment Market, by Disease Type, 2018 - 2030 (USD Billion)
  • Table 96 Middle East & Africa: Transthyretin Amyloidosis Treatment Market, by Type, 2018 - 2030 (USD Billion)
  • Table 97 Middle East & Africa: Transthyretin Amyloidosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 98 UAE: Transthyretin Amyloidosis Treatment Market, by Therapy, 2018 - 2030 (USD Billion)
  • Table 99 UAE: Transthyretin Amyloidosis Treatment Market, by Disease Type, 2018 - 2030 (USD Billion)
  • Table 100 UAE: Transthyretin Amyloidosis Treatment Market, by Type, 2018 - 2030 (USD Billion)
  • Table 101 UAE: Transthyretin Amyloidosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 102 Saudi Arabia: Transthyretin Amyloidosis Treatment Market, by Therapy, 2018 - 2030 (USD Billion)
  • Table 103 Saudi Arabia: Transthyretin Amyloidosis Treatment Market, by Disease Type, 2018 - 2030 (USD Billion)
  • Table 104 Saudi Arabia: Transthyretin Amyloidosis Treatment Market, by Type, 2018 - 2030 (USD Billion)
  • Table 105 Saudi Arabia: Transthyretin Amyloidosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 106 South Africa: Transthyretin Amyloidosis Treatment Market, by Therapy, 2018 - 2030 (USD Billion)
  • Table 107 South Africa: Transthyretin Amyloidosis Treatment Market, by Disease Type, 2018 - 2030 (USD Billion)
  • Table 108 South Africa: Transthyretin Amyloidosis Treatment Market, by Type, 2018 - 2030 (USD Billion)
  • Table 109 South Africa: Transthyretin Amyloidosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 110 Israel: Transthyretin Amyloidosis Treatment Market, by Therapy, 2018 - 2030 (USD Billion)
  • Table 111 Israel: Transthyretin Amyloidosis Treatment Market, by Disease Type, 2018 - 2030 (USD Billion)
  • Table 112 Israel: Transthyretin Amyloidosis Treatment Market, by Type, 2018 - 2030 (USD Billion)
  • Table 113 Israel: Transthyretin Amyloidosis Treatment Market, by Distribution Channel, 2018 - 2030 (USD Billion)

List of Figures

Figure 1. Global Transthyretin Amyloidosis Treatment Market, 2018 - 2030 (USD Billion)

Figure 2. Integrated Ecosystem

Figure 3. Research Methodology: Top-Down & Bottom-Up Distribution Channel

Figure 4. Market by Geography

Figure 5. Porter's Five Forces

Figure 6. Market by Therapy

Figure 7. Global Transthyretin Amyloidosis Treatment Market, by Therapy, 2021 & 2030 (USD Billion)

Figure 8. Market by Distribution Channel

Figure 9. Global Transthyretin Amyloidosis Treatment Market, by Distribution Channel, 2021 & 2030 (USD Billion)

Figure 10. Market by Disease Type

Figure 11. Global Transthyretin Amyloidosis Treatment Market, by Disease Type, 2021 & 2030 (USD Billion)

Figure 12. Market by Type

Figure 13. Global Transthyretin Amyloidosis Treatment Market, by Type, 2021 & 2030 (USD Billion)

Figure 14. Transthyretin Amyloidosis Treatment Market Assessment, By Geography, 2018 - 2030 (USD Billion)

Figure 15. Strategic Analysis - Transthyretin Amyloidosis Treatment Market